Pharmaceutical and life sciences R&D facility investment
Total capital investment planned or committed to pharmaceutical and life sciences research and development facilities.
Unit million GBP Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Pharmaceutical and life sciences R&D facility investment
United Kingdom, as of 28 Jul 2026
Every record
All records
1 record · 1 region · 2026
| Period | Value | Source | Type |
|---|---|---|---|
| United Kingdom 1 record | |||
| as of 28 Jul 2026 | 400 million GBP | GSK · 28 Jul 2026 | estimate |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK | GSK | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Pharmaceutical and life sciences R&D facility investment. Retrieved from https://statorigin.org/indicators/pharmaceutical-and-life-sciences-r-d-facility-investment